Healthcare · Pharmaceutical expenditure
Zambia's pharmaceutical expenditure is 1.40 % GDP of GDP in 2026, ranking 68th out of 197 countries. This figure reflects limited access to modern medicines: most drugs are imported, and local production is virtually nonexistent. High logistics costs to remote regions and low purchasing power constrain the market. Meanwhile, the government subsidizes antimalarial and antiretroviral drugs, which form the backbone of the pharmaceutical budget.
Data for 2026 · unit: % GDP
Position
#68 / 197
Zambia world ranking
Country position on the scale from last to first place for this indicator.
ZM
#68
#197#1
Trend
Change over time
Change in indicator over the available period.
0.80
1990
0.90
2000
1.10
2010
1.30
2020
1.40
2026
Values — % GDP
Comparison
Top countries by Pharmaceutical expenditure
Where Zambia stands in the world ranking.
1
USUSA
2.65
2
NLNetherlands
2.60
3
NONorway
2.50
4
MCMonaco
2.40
4
NZNew Zealand
2.40
6
DEGermany
2.35
7
JPJapan
2.30
8
FRFrance
2.25
Full world rankingarrow_forward
People also search for
Other pages of the reference by this indicator.
Frequently asked questions
Pharmaceutical expenditure in Zambia — how much?
Based on 2026 data — 1.40 % GDP. This is rank #68 out of 197 countries.
What is Zambia's rank by Pharmaceutical expenditure?
Zambia ranks #68 out of 197 countries in the world ranking by «Pharmaceutical expenditure».
How has Pharmaceutical expenditure changed in Zambia?
Over the available period the indicator changed from 0.80 to 1.40 % GDP.